Lifecore Biomedical Inc
NASDAQ:LFCR

Watchlist Manager
Lifecore Biomedical Inc Logo
Lifecore Biomedical Inc
NASDAQ:LFCR
Watchlist
Price: 6.76 USD -1.46%
Market Cap: 250.3m USD

Wall Street
Price Targets

LFCR Price Targets Summary
Lifecore Biomedical Inc

Wall Street analysts forecast LFCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LFCR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

Lowest
Price Target
10.1 USD
49% Upside
Average
Price Target
10.2 USD
51% Upside
Highest
Price Target
10.5 USD
55% Upside
Lifecore Biomedical Inc Competitors:
Price Targets
603517
Juewei Food Co Ltd
17% Downside
BRITANNIA
Britannia Industries Ltd
5% Upside
600872
Jonjee Hi-tech Industrial and Commercial Holding Co Ltd
21% Upside
EBRO
Ebro Foods SA
18% Upside
AFISH
Arctic Fish Holding AS
24% Upside

Revenue
Forecast

Revenue Estimate
Lifecore Biomedical Inc

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -15%. The projected CAGR for the next 4 years is 11%.

-15%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Lifecore Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
66%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is LFCR's stock price target?
Price Target
10.2 USD

According to Wall Street analysts, the average 1-year price target for LFCR is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.

What is Lifecore Biomedical Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Lifecore Biomedical Inc's revenue is -15%. The projected CAGR for the next 4 years is 11%.

Back to Top